Circulating IL-21 levels increase during early simian-human immunodeficiency virus infection in macaques

被引:5
|
作者
Zhao, Chang-cheng [1 ,2 ,3 ]
Xue, Jing [1 ,2 ]
Cong, Zhe [1 ,2 ]
Gao, Xi-qiang [1 ,2 ]
Zhang, Wei-lun [1 ,2 ]
Chen, Ting [1 ,2 ]
Wu, Fang-xin [1 ,2 ]
Xiong, Jing [1 ,2 ]
Ju, Bin [1 ,2 ]
Su, Aihua [1 ,2 ]
Wei, Qiang [1 ,2 ]
Qin, Chuan [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Inst Lab Anim Sci, Beijing 100021, Peoples R China
[2] Comparat Med Ctr, Beijing 100021, Peoples R China
[3] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Peoples R China
关键词
RENAL-CELL CARCINOMA; T-CELLS; METASTATIC MELANOMA; VIRAL CONTROL; AIDS; INTERLEUKIN-21; LYMPHOCYTES; ACTIVATION; CD4;
D O I
10.1007/s00705-012-1534-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The cytokine interleukin-21 (IL-21) regulates viral pathogenesis in individuals infected with human and simian immunodeficiency viruses. However, because the time of initial infection with HIV in humans is rarely known, the dynamics of IL-21 production during the first weeks have not been adequately explored. In the present study, we used rhesus macaques to model the first stages of infection. Twenty-two rhesus macaques were infected rectally with simian-human immunodeficiency virus (SHIV)-1157ipd3N4, and for 12 weeks, replication of the virus, the numbers of CD4+ and CD8+ T cells, and the levels of plasma IL-21 were monitored. Our study demonstrated that plasma levels of IL-21 increased during the early phase of SHIV infection when compared with the values observed before inoculation. We conclude that IL-21 has a likely role in the immunopathogenesis of HIV/SIV/SHIV.
引用
收藏
页码:853 / 858
页数:6
相关论文
共 50 条
  • [41] Lymphocyte activation during acute simian/human immunodeficiency virus SHIV89.6PD infection in macaques
    Wallace, M
    Waterman, PM
    Mitchen, JL
    Djavani, M
    Brown, C
    Trivedi, P
    Horejsh, D
    Dykhuizen, M
    Kitabwalla, M
    Pauza, CD
    JOURNAL OF VIROLOGY, 1999, 73 (12) : 10236 - 10244
  • [42] Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus
    Garber, David A.
    Guenthner, Patricia
    Mitchell, James
    Ellis, Shanon
    Gazumyan, Anna
    Nason, Martha
    Seaman, Michael S.
    McNicholl, Janet M.
    Nussenzweig, Michel C.
    Heneine, Walid
    AIDS, 2021, 35 (10) : 1567 - 1574
  • [43] Understanding the basis of CD4+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus
    Etemad-Moghadam, B
    Rhone, D
    Steenbeke, T
    Sun, Y
    Manola, J
    Gelman, R
    Fanton, JW
    Racz, P
    Tenner-Racz, K
    Axthelm, MK
    Letvin, NNL
    Sodroski, J
    VACCINE, 2002, 20 (15) : 1934 - 1937
  • [44] Giant cell encephalitis and microglial infection with mucosally transmitted simian-human immunodeficiency virus SHIVSF162P3N in rhesus macaques
    Carole Harbison
    Ke Zhuang
    Agegnehu Gettie
    James Blanchard
    Heather Knight
    Peter Didier
    Cecilia Cheng-Mayer
    Susan Westmoreland
    Journal of NeuroVirology, 2014, 20 : 62 - 72
  • [45] Giant cell encephalitis and microglial infection with mucosally transmitted simian-human immunodeficiency virus SHIVSF162P3N in rhesus macaques
    Harbison, Carole
    Zhuang, Ke
    Gettie, Agegnehu
    Blanchard, James
    Knight, Heather
    Didier, Peter
    Cheng-Mayer, Cecilia
    Westmoreland, Susan
    JOURNAL OF NEUROVIROLOGY, 2014, 20 (01) : 62 - 72
  • [46] Neutralizing antibodies: a potent line of defense against acute and chronic simian-human immunodeficiency virus infection
    Ruprecht, RM
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 2003, : 45 - 50
  • [47] Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus
    Joag, SV
    Li, ZA
    Wang, CY
    Foresman, L
    Jia, FL
    Stephens, EB
    Wu, ZG
    Narayan, O
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (04) : 391 - 394
  • [48] Estimating the Timing of Early Simian-Human Immunodeficiency Virus Infections: a Comparison between Poisson Fitter and BEAST
    Giorgi, Elena E.
    Li, Hui
    Bhattacharya, Tanmoy
    Shaw, George M.
    Korber, Bette
    MBIO, 2020, 11 (02):
  • [49] Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses
    Reimann, KA
    Parker, RA
    Seaman, MS
    Beaudry, K
    Beddall, M
    Peterson, L
    Williams, KC
    Veazey, RS
    Montefiori, DC
    Mascola, JR
    Nabel, GJ
    Letvin, NL
    JOURNAL OF VIROLOGY, 2005, 79 (14) : 8878 - 8885
  • [50] Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge
    Hofmann-Lehmann, R
    Vlasak, J
    Rasmussen, RA
    Smith, BA
    Baba, TW
    Liska, V
    Ferrantelli, F
    Montefiori, DC
    McClure, HM
    Anderson, DC
    Bernacky, BJ
    Rizvi, TA
    Schmidt, R
    Hill, LR
    Keeling, ME
    Katinger, H
    Stiegler, G
    Cavacini, LA
    Posner, MR
    Chou, TC
    Andersen, J
    Ruprecht, RM
    JOURNAL OF VIROLOGY, 2001, 75 (16) : 7470 - 7480